hotspot -WSS

hotspot

author：hotspot 2025-09-27 16:47:21 - browse：44

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： What nurses really want: sufficient staffing for patient care

focus

WSS

After gene therapy, two congenitally deaf children hear for the first time

6 surprising facts about sugar

Steward Health Care expansion into Malta flopped

How to improve immunocompromised access to mAb treatments

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

U.K. officials, researchers try to ease path for bespoke genetic treatments

hotspot

hotspot

leisure time

Guidelines to prevent youth baseball injuries need more muscle

Bring on the sabbaticals for nurses

Alkermes shareholders re

Making AI in medicine accessible to smaller, and rural hospitals

How to save PrEP access — and even expand it

Diabetes management: Digital health tools fall short, study says

The cancer drug shortage isn’t new — and neither are the solutions

Asbestos ban is immediate, but health effects will linger for decades

Medicare proposal to cover medical devices draws a mixed reaction

6 surprising facts about sugar

Wikipedia

'Patient friction coefficient' can gauge a clinical trial's patient burden

Bird flu outbreak in cows is latest avian flu curveball

Medicare says breakthrough device reimbursement rule to come by summer

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

What nurses really want: sufficient staffing for patient care

Researchers on aging grapple with how to calculate biological age

leisure time

explore

focus

focus